Can-Fite BioPharma annual depreciation and amortization
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Can-Fite BioPharma Depreciation & Amortization Growth & History (CANF)
Can-Fite BioPharma's depreciation and amortization was $24,000 for fiscal 2025.
View full Can-Fite BioPharma company overviewCan-Fite BioPharma annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24,000 | $17,000 | +242.86% |
| 2024 | 2024-12-31 | $7,000 | −$8,000 | −53.33% |
| 2023 | 2023-12-31 | $15,000 | $1,000 | +7.14% |
| 2022 | 2022-12-31 | $14,000 | $0 | 0.00% |
| 2021 | 2021-12-31 | $14,000 | $2,000 | +16.67% |
| 2020 | 2020-12-31 | $12,000 | −$2,000 | −14.29% |
| 2019 | 2019-12-31 | $14,000 | $0 | 0.00% |
| 2018 | 2018-12-31 | $14,000 | $11,000 | +366.67% |
| 2017 | 2017-12-31 | $3,000 | −$1,000 | −25.00% |
| 2016 | 2016-12-31 | $4,000 | — | — |
Can-Fite BioPharma depreciation and amortization trends
Over the last five fiscal years, Can-Fite BioPharma's depreciation and amortization increased from $12,000 to $24,000, a change of $12,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Can-Fite BioPharma source filings ↗